Monday, 7 April 2014

Daiichi has failed to run Ranbaxy successfully: Malvinder Singh

Mumbai-based Sun Pharma has said it will acquire troubled Indian drug maker Ranbaxy in a $4-billion (Rs. 24,000 crore at 60 rupees to the US dollar) deal.





from NDTV News - Profit http://ift.tt/QWhXj5

No comments:

Post a Comment